Back to search
Proliferative Vitreoretinopathy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Proliferative Vitreoretinopathy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Proliferative Vitreoretinopathy trials you may qualify forThis study has two main objectives. The first objective is to study the pharmacokinetics of topical netarsudil administration in the posterior segment of the ey…
Intravitreal topotecan has anti-inflammatory, anti-proliferative and anti-fibrotic activity that we hypothesize may exhibit high efficacy for the treatment of p…
I. Title Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial * Today's Date: Septem…
Background: Few large randomized controlled trials provide strong evidence to guide surgical repair of primary rhegmatogenous retinal detachment (RRD) repair. T…
Disease or general study area: Uncomplicated rhegmatogenous retinal detachment (RRD) and risk of proliferative vittroretinopathy (PVR) Purpose and nature of th…
The goal of this clinical trial is to evaluate the safety and efficacy of intravitreal topotecan for the treatment of patients with rhegmatogenous retinal detac…
PVR remains the major cause of surgical failure in RRD repair.1 Prompt surgical management is the standard therapy in RRD repair. However, in many places, vitre…